Natalie Mount, Executive Director, Development Lead at Pfizer Regenerative Medicine, presented at last year's Stem Cells USA & Regenerative Medicine Congress on the topic, âCell therapy in big pharma: the Pfizer Neusentis approach.'
In her presentation, Natalie gives an overview on:
- What approach is Pfizer taking to developing innovative regenerative medicine projects?
- Cell therapy portfolio update and progress including the Athersys MultiStem Project and the London AMD Project
- Challenges and opportunities for Big Pharma in cell therapy
For up to date information on the stem cells and regenerative medicine market, register now for Stem Cells USA & Regenerative Medicine Congress.